- Corporate Officers - S
- Sherman Matthew L
Insider Trading History of Sherman Matthew L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sherman Matthew L since 2014.
This trader's CIK number is 1325710.
At the time of last reporting, Sherman Matthew L was the EVP & Chief Medical Officer of Deciphera Pharmaceuticals, Inc.. (stock ticker symbol DCPH).
Also see all insider trading activities at Deciphera Pharmaceuticals, Inc..
Note that in the past
Sherman Matthew L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Deciphera Pharmaceuticals, Inc. (DCPH) by Sherman Matthew L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | DCPH | 0 | $0 | 5,050 | $76,075 | 0 | $0 |
| 2023 | DCPH | 0 | $0 | 7,928 | $104,162 | 0 | $0 |
| 2022 | DCPH | 0 | $0 | 2,752 | $27,911 | 0 | $0 |
| 2021 | DCPH | 0 | $0 | 2,791 | $94,649 | 0 | $0 |
| 2020 | DCPH | 0 | $0 | 0 | $0 | 2,904 | $99,984 |
Yearly summary of insider trading at Pulmatrix, Inc. (PULM) by Sherman Matthew L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | PULM | 20,000 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Sherman Matthew L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | XLRN | 0 | $0 | 9,233 | $373,333 | 0 | $0 |
| 2017 | XLRN | 0 | $0 | 36,400 | $1,286,918 | 8,000 | $56,960 |
| 2016 | XLRN | 0 | $0 | 52,000 | $1,730,170 | 52,896 | $286,413 |
| 2015 | XLRN | 0 | $0 | 60,000 | $2,063,967 | 73,600 | $230,601 |
| 2014 | XLRN | 0 | $0 | 85,000 | $2,715,026 | 68,082 | $107,862 |
Insider trading activities at 3 companies by Sherman Matthew L:
1. Deciphera Pharmaceuticals, Inc. (DCPH)
2. Pulmatrix, Inc. (PULM)
3. Acceleron Pharma Inc (XLRN)
Table 1. Insider trading of Deciphera Pharmaceuticals, Inc. (DCPH) by Sherman Matthew L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-02-16 | DCPH | Sale | 2,615 | 15.62 | 40,841 |
| 2024-01-16 | DCPH | Sale | 2,435 | 14.47 | 35,234 |
| 2023-10-30 | DCPH | Sale | 2,360 | 12.02 | 28,362 |
| 2023-10-02 | DCPH | Sale | 2,942 | 12.68 | 37,304 |
| 2023-06-16 | DCPH | Sale | 1,655 | 14.40 | 23,835 |
| 2023-02-16 | DCPH | Sale | 971 | 15.10 | 14,661 |
| 2022-06-16 | DCPH | Sale | 1,768 | 10.75 | 19,006 |
| 2022-02-16 | DCPH | Sale | 984 | 9.05 | 8,905 |
| 2021-10-04 | DCPH | Sale | 2,659 | 33.17 | 88,199 |
| 2021-02-16 | DCPH | Sale | 132 | 48.87 | 6,450 |
| 2020-12-09 | DCPH | Option Ex | 207 | 34.43 | 7,127 |
| 2020-11-16 | DCPH | Option Ex | 2,697 | 34.43 | 92,857 |
Table 2. Insider trading of Pulmatrix, Inc. (PULM) by Sherman Matthew L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-03 | PULM | Buy | 20,000 | .00 | 0 |
Table 3. Insider trading of Acceleron Pharma Inc (XLRN) by Sherman Matthew L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-03 | XLRN | Sale | 4,600 | 38.66 | 177,835 |
| 2018-01-03 | XLRN | Sale | 4,633 | 42.20 | 195,498 |
| 2017-09-12 | XLRN | Sale | 18,400 | 39.16 | 720,488 |
| 2017-07-05 | XLRN | Sale | 16,000 | 32.00 | 512,000 |
| 2017-07-05 | XLRN | Option Ex | 8,000 | 7.12 | 56,960 |
| 2017-01-04 | XLRN | Sale | 2,000 | 27.21 | 54,430 |
| 2016-08-10 | XLRN | Option Ex | 18,896 | 6.20 | 117,155 |
| 2016-07-07 | XLRN | Option Ex | 6,000 | 5.28 | 31,680 |
| 2016-07-01 | XLRN | Option Ex | 14,000 | 4.75 | 66,458 |
| 2016-07-01 | XLRN | Sale | 26,000 | 34.55 | 898,170 |
| 2016-04-07 | XLRN | Option Ex | 14,000 | 5.08 | 71,120 |
| 2016-04-06 | XLRN | Sale | 2,080 | 32.00 | 66,560 |
| 2016-04-07 | XLRN | Sale | 23,920 | 32.00 | 765,440 |
| 2015-10-15 | XLRN | Sale | 6,000 | 23.30 | 139,830 |
| 2015-09-16 | XLRN | Sale | 2,000 | 33.91 | 67,830 |
| 2015-08-24 | XLRN | Option Ex | 20,000 | 3.88 | 77,600 |
| 2015-08-18 | XLRN | Sale | 7,000 | 31.39 | 219,751 |
| 2015-08-18 | XLRN | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-07-20 | XLRN | Option Ex | 4,800 | 2.78 | 13,343 |
| 2015-07-20 | XLRN | Sale | 6,000 | 32.76 | 196,536 |
| 2015-06-18 | XLRN | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-06-18 | XLRN | Sale | 7,000 | 31.40 | 219,821 |
| 2015-05-18 | XLRN | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-05-18 | XLRN | Sale | 7,000 | 32.30 | 226,135 |
| 2015-04-20 | XLRN | Sale | 5,000 | 33.52 | 167,575 |
| 2015-04-20 | XLRN | Option Ex | 4,000 | .48 | 1,920 |
| 2015-04-16 | XLRN | Option Ex | 12,000 | 3.88 | 46,560 |
| 2015-03-18 | XLRN | Option Ex | 4,800 | 2.78 | 13,343 |
| 2015-03-18 | XLRN | Sale | 6,000 | 41.31 | 247,848 |
| 2015-03-04 | XLRN | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-03-04 | XLRN | Sale | 7,000 | 41.04 | 287,273 |
| 2015-01-20 | XLRN | Option Ex | 5,600 | 2.78 | 15,567 |
| 2015-01-20 | XLRN | Sale | 7,000 | 41.62 | 291,368 |
| 2014-12-18 | XLRN | Option Ex | 4,000 | .48 | 1,920 |
| 2014-12-18 | XLRN | Sale | 5,000 | 40.31 | 201,535 |
| 2014-12-17 | XLRN | Option Ex | 2,000 | 3.88 | 7,760 |
| 2014-12-10 | XLRN | Option Ex | 4,000 | 5.08 | 20,320 |
| 2014-12-10 | XLRN | Sale | 5,000 | 43.52 | 217,615 |
| 2014-11-18 | XLRN | Option Ex | 4,082 | .48 | 1,959 |
| 2014-11-18 | XLRN | Sale | 5,082 | 34.00 | 172,803 |
| 2014-11-12 | XLRN | Option Ex | 3,918 | 3.44 | 13,477 |
| 2014-11-12 | XLRN | Sale | 4,918 | 33.09 | 162,736 |
| 2014-10-20 | XLRN | Sale | 4,918 | 29.11 | 143,162 |
| 2014-10-08 | XLRN | Sale | 5,082 | 29.78 | 151,357 |
| 2014-10-08 | XLRN | Option Ex | 4,082 | 1.80 | 7,347 |
| 2014-09-18 | XLRN | Sale | 5,000 | 25.48 | 127,425 |
| 2014-09-03 | XLRN | Option Ex | 4,000 | 1.80 | 7,200 |
| 2014-09-03 | XLRN | Sale | 5,000 | 26.00 | 129,985 |
| 2014-08-18 | XLRN | Sale | 2,500 | 29.77 | 74,412 |
| 2014-08-14 | XLRN | Option Ex | 6,000 | 1.14 | 6,839 |
| 2014-08-14 | XLRN | Sale | 7,500 | 29.95 | 224,602 |
| 2014-08-12 | XLRN | Option Ex | 8,000 | 1.80 | 14,400 |
| 2014-07-23 | XLRN | Option Ex | 10,000 | 1.80 | 18,000 |
| 2014-07-18 | XLRN | Sale | 2,500 | 26.22 | 65,557 |
| 2014-07-09 | XLRN | Option Ex | 6,000 | .48 | 2,880 |
| 2014-07-09 | XLRN | Sale | 7,500 | 29.04 | 217,815 |
| 2014-06-18 | XLRN | Sale | 2,500 | 34.31 | 85,775 |
| 2014-06-11 | XLRN | Sale | 7,500 | 33.24 | 249,300 |
| 2014-06-11 | XLRN | Option Ex | 6,000 | .48 | 2,880 |
| 2014-05-28 | XLRN | Option Ex | 6,000 | .48 | 2,880 |
| 2014-05-28 | XLRN | Sale | 7,500 | 30.98 | 232,350 |
| 2014-05-19 | XLRN | Sale | 2,500 | 31.79 | 79,482 |
| 2014-04-22 | XLRN | Sale | 5,000 | 35.82 | 179,115 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sherman Matthew L
(EVP & Chief Medical Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.